Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD-Reference-Cited by-同舟云学术

Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD

Published:2020-10 Issue:19 Volume:13 Page:2251-2262
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Kogame Norihiro,Guimarães Patricia O.,Modolo Rodrigo,De Martino Fernando,Tinoco Joao,Ribeiro Expedito E.,Kawashima Hideyuki,Ono Masafumi,Hara Hironori,Wang Rutao,Cavalcante Rafael,Moulin Bruno,Falcão Breno A.A.,Leite Rogerio S.,de Almeida Sampaio Fernanda Barbosa,Morais Gustavo R.,Meireles George C.,Campos Carlos M.,Onuma Yoshinobu,Serruys Patrick W.,Lemos Pedro A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Levine;J Am Coll Cardiol,2016

2. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis;Yin;BMJ,2019

3. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial;Watanabe;JAMA,2019

4. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial;Hahn;JAMA,2019

5. Ticagrelor with or without aspirin in high-risk patients after PCI;Mehran;N Engl J Med,2019

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualization of prasugrel dose for patients with acute myocardial infarction;International Journal of Cardiology;2024-10

2. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials;The Lancet;2024-09

3. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

4. Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review;Journal of Arrhythmia;2024-08-08

5. Does one size really fit all? The case for personalized antiplatelet therapy in interventional cardiology;Future Cardiology;2024-08-02